Skip to Content

Soolantra Approval History

  • FDA approved: Yes (First approved December 19th, 2014)
  • Brand name: Soolantra
  • Generic name: ivermectin
  • Dosage form: Cream
  • Company: Galderma Laboratories, L.P.
  • Treatment for: Rosacea

Soolantra (ivermectin) is a topical antiparasitic with anti-inflammatory properties for the treatment of rosacea potentially caused by the microscopic skin mite Demodex folliculorum.

Development History and FDA Approval Process for Soolantra

DateArticle
Dec 23, 2014Approval Galderma Receives FDA Approval of Soolantra (ivermectin) Cream for Rosacea

Disclaimer: Every effort has been made to ensure that the information provided here is accurate, up-to-date and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. This information has been compiled for use by healthcare practitioners and consumers in the United States. The absence of a warning for a given drug or combination thereof in no way should be construed to indicate that the drug or combination is safe, effective or appropriate for any given patient. If you have questions about the substances you are taking, check with your doctor, nurse or pharmacist.

Hide